Mrs. J.JANIFER JASMINE

*.Name in Full: Mr/Miss/Mrs/Dr.

(IN CAPITAL LETTERS)

Mrs. J.JANIFER JASMINE

**/*, ********** ******* ******,

2. Address:(i) Present:

Perambur

Chennai-600011

Mrs. J.JANIFER JASMINE

(ii)Permanent:

37/2, Siddthather street

Kaspa- Vellore-600003

984*******

(iii)Contact Telephone No. & Mobile No.

ac4q5n@r.postjobfree.com

(iv)E.Mail address :

Married Indian

3.Marital Status: Married/ Un-Married: Nationality:

4. Particulars of all degree and technical qualifications

Examination or Degree Obtained

Class or Division

Subject taken

Year of Passing

Class/Division

Higher secondary (+2)

First Class

Group-B

1989-1990

First Class

Degree of Bachelor of Science (Zoology)

First Class

(Zoology)

Mar-1991-1993

First Class

Diploma in Medical Microbiology

First Class

Medical Microbiology

Oct-1994-1995

First Class

Compulsory Fulltime Internship

Satisfactory

Medical Microbiology

Feb-1995-Oct-1995

Satisfactory

M.Sc (Microbiology)

First Class

(Microbiology)

Jan-2014

First Class

5. Particulars of Employments held in chronological order:-

Name of

employer &

Address

Date of

joining

Date of

leaving

Nature of work

performed or being

Christian Medical College & Hospital-Vellore

Sep-1995

Mar-1997

Junior Microbiologist

Voluntary Health Services

Rotary Central TTK Blood bank-

Adayar-Chennai

April-1998

Dec-1998

Blood Bank Technologist

M.V.Hospital for Diabetes (P) Ltd- Royapuram-Chennai

June-1999

May-2015

Senior Microbiologist & Research Associate

Rajiv Gandhi Government General Hospital (RGGGH) Department of Hepatology- Chennai

Aug-2015

May-2017

Research Associate

The Tamil nadu Dr. M.G.R. Medical university-guindy-chennai

Aug-2017

Jan-2018

Documentation Officer

6. Total Research Experience in details in each area:

a.Published Research Articles details

S.no

Nature of Journal

Topic

Journal

Year of Publication and Institution

1.

International Journals

Bone Mineral Density Assessment in Chronic Liver Disease

Archives in Cancer Research;Volume 5 Issue 1;March 2017 ISSN: 2254-6081

2017

Rajiv Gandhi Government General Hospital (RGGGH)

Department of Hepatology-2017

2.

Current Prevalence Of HCV In Patients With Liver Disease And Its Related Profile

International Journal of Innovative Research and Advanced Studies (IJIRAS) Volume 4 Issue 2, February 2017 ISSN: 2394-4404

2017

Rajiv Gandhi Government General Hospital (RGGGH)

Department of Hepatology-2017

3.

“BLOOD”: prevalence of Blood borne infectious diseases in a Large population Observed Over blood Donors

International Journal of Current Research

9, Issue, 02, pp.46157-

46161, February, 2017

2017

Rajiv Gandhi Government General Hospital (RGGGH)

Department of Hepatology-2017

4.

Outcome of Therapy in HCV Patients in a public health tertiary care center

Liver Disease Transplant; (2016) 5:3. doi:10.4172/2325-9612.1000141

2016

Rajiv Gandhi Government General Hospital (RGGGH)

Department of Hepatology-2016

5.

Bioburden Vs Antibiogram of Diabetic Foot Infection

International journal on clinical Research on Foot & Ankle:2013;Vol-1 ; Issue -3;Page 1 -3

2013

M.V.Hospital for Diabetes (P) Ltd- Chennai-2013

S.no

Nature of Journal

Topic

Journal

Year of Publication and Institution

6.

National Journals

Letter to the Editor-Prevalence of lower Urinary Tract Infection in South Indian Type 2 Diabetic subjects: (IJON).

Indian journal of Nephrology:2009 Vol-19 :Issue-3:107- 111

2010

M.V.Hospital for Diabetes (P) Ltd- Chennai-2010

7.

Prevalence of lower Urinary Tract Infection in South Indian Type 2 Diabetic subjects.

Indian journal of Nephrology:2009 Vol-19 :Issue-3:107- 111

2009

M.V.Hospital for Diabetes (P) Ltd- Chennai-2009

8.

Prevalence of pathogens in Diabetic foot inspection in South Indian 1Type 2 Diabetic patients.

JAPI : 2002 ;Vol-50:Page no 1013 – 1016

2002

M.V.Hospital for Diabetes (P) Ltd- Chennai-2002

6. b. Accepted Manuscripts:

Nature of Journal

Topic

Journal

Institution

1.

Cystatin - C: "A renal marker in patients with cirrhosis

Asian Journal of Science and Technology

Yet to publish

Rajiv Gandhi Government General Hospital

(RGGGH)Department of Hepatology-2017

Research Experience

M.V.Hospital for Diabetes (P) Ltd: Research in Diabetes mellitus and its complications was target point of research in diabetes. Infections like diabetic foot infection and urinary tract infection were the most common.

2002 publication

1.In 2002 publication, patients with diabetic foot infection were recruited.

2.Aim of the study is determine prevalence of pathogens, Association of Wagners grading, duration diabetes and healing were also studied.

3.Results were, Enterobacteriaceae family of pathogens, Longer period of healing time required for anaerobes than aerobes and liner increase of Anaerobes with increasing Wagner’s grading.

2009 and 2010 publication

1.In 2009 publication, Patients with urinary tract infection (UTI) (asymptomatic and symptomatic) were recruited.

2.Aims of the study were prevalence of UTI, causative pathogens, antimicrobial pattern and recurrence of UTI in diabetic patients.

3.Results were, polymicrobial nature of infection was found in UTI. Prevalence of UTI.

4.Gram negative pathogens were higher than gram positive pathogens in UTI.

5.Prevalence of UTI was higher in Women than men. Incidence of UTI increased with increased duration of diabetes.

6.Obese women were more prone for UTI than men.

7.Poor glycemic control was significantly associated with UTI.

2013 publication

1.In 2013 publication, Biobuden vs Antibiogram, patients with diabetic foot infection were selected.

2.Aim of the study is appropriate antimicrobials to specific pathogens. Optimal antimicrobial sensitivity of various antimicrobial agents. Choice of drug for MRSA and ESBL.

3.In the results, Iimipenem showed higher susceptibility followed by Amikacin.

4.Beta-lactamase inhibitors showed higher susceptibility than mono-antimicrobial agents.

5.Gram positive pathogens were susceptible to Doxycycline, Vancomycin and Clindamycin.

Rajiv Gandhi Government General Hospital (RGGGH)- Department of Hepatology

2016 publication

1.In 2016 publication, patients with reactive Hepatitis C virus (HCV) were selected.

2.Aim of the study were, outcome of therapy, gender wise distribution of therapy received for HCV, Treatment Success rate, Treatment Failure rate and rate of relapses.

3.To study the duration of treatment.

4.The results were women received lesser therapy than men. Treatment success was higher followed by relapses cases.

5.12 weeks of treatment regimen were appropriate to treat HCV.

6.Genotype 2 was highly treatable.

7.Door step therapy for female will reduce the transmission of HCV among the population.

2017 publications

I –Blood manuscript

1.In 2017, blood publication the aim of the study were, prevalence of Rh positivity, distribution of blood groups, weight related to blood donors, test validation and look back process.

2.The results were, among the 1, 70,001 blood donor, HBsAg were found higher followed by HCV. Minimal number donors were with HIV.

3.HIV reactive donors were decreased weight and older age. HBsAg reactive donors were younger age and increased weight and HCV reactive donors were increased weight and age

4.Prevalent blood group was “O”

5.In the look back process, reactive donors responded less to post donation counseling.

II-Prevalence of HCV in patients with liver diseases-2017

1.Patients with HCV were selected.

2.Aim of the study were, to study the prevalence of HCV in patients with liver diseases, serological and virological reactivity, HCV related patients profile like age, habits, biological marker, obesity, co-morbidities and hepato-cellular carcinoma. To study the detection of liver stiffness by various methods.

3.The results were 1.3% prevalence and there was a statistical significance between serological and virological reactivity.

4.Double fold incidence of HCV was observed after the year of 2013.

5.Unhealthy bad habits like alcohol and smoking were found among the HCV reactive patients.

6.Considerable percentage of obesity and diabetes mellitus were observed among the HCV reactive patients.

7.Higher numbers of patients with HCV were with co-morbid conditions like CLD, CKD and extra-hepatic co-morbidities.

8.Elevation of biological markers like liver enzymes was observed.

9.Best method to detect liver stiffness was Fibroscan.

Summary of the Research Experience:

1.15 years of Research experience in the field of Diabetic foot infection, Urinary Tract Infection, microbiology research, liver diseases, HCV, reduce bone minerals and Cystatin-C levels in serum.

2.Five (4) international publications with First, second and corresponding author and three (3) National paper with first and second authorship.

3.One accepted international publications, yet to be published.

4.15 years of experience in the field of report witting of patient’s details, anthropometric details, clinical details, biological markers, symptoms, Adverse effects of drugs, advantages and disadvantages of drugs, test validation and usage of bio-markers.

Summary of the Experience as Senior Microbiologist:

1.19 years of experience as Senior Microbiologist in the field of Medical Microbiology

2.Water Analysis, Surveillance, Operation theater infection control measures, Infection Control Measures of ICU and various departments of health care settings.

3.Sample collection for various tests, Preparation of Media, Sample processing, Microscopy, Incubation and identification of Pathogens, Interpretation of Pathogens, Verification of result, Report typing, dispatching of reports and Documentation according to NABL procedure.

4.19 years of experience in the field of report witting of patient’s details, anthropometric details, clinical details, biological markers, symptoms, Adverse effects of drugs, advantages and disadvantages of drugs, test validation and usage of bio-markers.

5.16 Years of writing SOPs for various procedures in the field of Microbiology according to NABL norms.

7. Major other academic achievements:

a. Poster presentation:

1.Optimal antimicrobial therapy in diabetic patients with infection in India:7th Annual conference -2009-RSSDI (Research Society for the study of Diabetes in India)

2.Inclusion of Chrome agar for early identification of Candida infection in South Indian Subjects with type 2 diabetes: 40th Annual conference – 2012 –RSSDI (Research Society for the study of Diabetes in India)

3.Bacterial etiology and prevalence of ESBL producers in diabetic foot infection in subjects with type 2 diabetes :40th Annual conference-2012- RSSDI (Research Society for the study of Diabetes in India)

4.Bioburden Vs Antibiogram of Diabetic Foot Infection: 2013 –DFSICON (Diabetic Foot Society of India Conference).

b. CME and Training

1.Participated in poster presentation in RSSDI – 2012

2.Participated in Strengthening of Laboratory Biosafety and Biosecurity and its role in laboratory accreditation: NACO -2011

3.Participated in 1st Annual meet of The Indian Academy of Tropical parasotiology and current scenario of Parsitic Infections- 2010

4.Participated in CME on common Fungal Infection in Clinical Practice:

Institute of Microbiology-Madras Medical College – 2010

5.Participated in workshop on Hospital Infection control practices by Andhra chamber of commerce : 2010

6.Participated in Continuing Medical Education & Inauguration of Indian Academy of Tropical Parasitology: Tamilnadu chapter :Madras Medical college:2009

7.Participated in Laboratory Technician training program Tamilnadu state AIDS control society :TANSACS : 2008

8.Participated in Laboratory Technologist training program in 6th National workshop on simple Diagnostic methods in Clinical Microbiology :JIPMER :2007

9.Participated in Program of Sputum smear Microscopy: REACH (Resource group for Education and Advocacy for community Health) and Tuberculosis Research center (TRC): 2004.

DECLARATION

I hereby declare that the entries in this form and the additional particulars, if any, furnished herewith are true to the best of my knowledge and belief.

J.Janifer Jasmine

Signature of Candidate

Place: Chennai

Date: 02.02.2018

Contact this candidate